Ikarian Capital
North America, Texas, United States, Dallas
Description
We leverage our co-founder’s medical and financial background to invest both long and short in biotechnology and pharmaceuticals.
Investor Profile
Ikarian Capital has backed more than 9 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 7 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Post Ipo Equity, Series Unknown, Series A rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Health Care, Therapeutics.
Stage Focus
- Post Ipo Equity (67%)
- Series Unknown (22%)
- Series A (11%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Life Science
- Pharmaceutical
- Genetics
- Medical
- Clinical Trials
- Oncology
- Robotics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
